Literature DB >> 1675144

Relation between adrenergic neurogenic contraction and alpha 1-adrenoceptor subtypes in dog mesenteric and carotid arteries and rabbit carotid arteries.

I Muramatsu1.   

Abstract

1. We examined the distribution of alpha 1-adrenoceptor subtypes and their relation to adrenergic neurogenic contraction induced by electrical transmural stimulation in the dog mesenteric and carotid arteries and the rabbit carotid artery. 2. In the dog mesenteric artery, contraction to noradrenaline was competitively inhibited by HV723 (pKB = 9.37) and prazosin (pKB = 8.40). Pretreatment with chlorethylclonidine (CEC) slightly attenuated only the contractions induced by low concentrations of noradrenaline. Contraction induced by electrical transmural stimulation was inhibited at lower concentrations of HV723 than of prazosin. 3. In the dog carotid artery, contraction to noradrenaline was inhibited with higher affinity by prazosin (pKB = 9.82) than by HV723 (pKB = 8.47). Prazosin was also more potent than HV723 in inhibiting the contraction to electrical stimulation. Pretreatment with CEC markedly attenuated or abolished contraction to noradrenaline and electrical stimulation. 4. In the rabbit carotid artery, prazosin inhibited noradrenaline-induced contraction biphasically (pKB = 9.91 and 8.60). After CEC pretreatment, contraction to noradrenaline was attenuated moderately and the high affinity site for prazosin was abolished. HV723 competitively inhibited the noradrenaline response with a similar pKB value (approximately 8.5) regardless of CEC treatment. Contraction to electrical stimulation was inhibited by prazosin more effectively than by HV723 in preparations not treated with CEC, while it was equipotently inhibited by both antagonists in CEC-treated preparations. 5. These results suggest that the contractions induced by endogenous and exogenous noradrenaline are mediated through the same subtypes of alpha,-adrenoceptor distributed in each artery; according to our recent subclassification: alpha 1N subtype in the dog mesenteric artery, alpha 1H subtype in the dog carotid artery and alpha lH and alpha 1L subtypes in the rabbit carotid artery. Different susceptibility to alpha l-adrenoceptor antagonists of sympathetic adrenergic responses in various blood vessels may be related to heterogeneous involvement of distinct alpha,-adrenoceptor subtypes in the sympathetic response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675144      PMCID: PMC1917914          DOI: 10.1111/j.1476-5381.1991.tb12155.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

Review 1.  Catecholamine action on smooth muscle.

Authors:  E Bülbring; T Tomita
Journal:  Pharmacol Rev       Date:  1987-03       Impact factor: 25.468

2.  Pharmacological studies on the selectivity of HV-723, a new alpha-1 adrenoceptor antagonist.

Authors:  M Oshita; Y Iwanaga; S Hashimoto; K Morikawa; I Muramatsu
Journal:  Jpn J Pharmacol       Date:  1988-07

3.  Evidence for ATP as a cotransmitter in dog mesenteric artery.

Authors:  M Machaly; H H Dalziel; P Sneddon
Journal:  Eur J Pharmacol       Date:  1988-02-16       Impact factor: 4.432

4.  Differential interactions of clonidine and methoxamine with the postsynaptic alpha-adrenoceptor of rabbit main pulmonary artery.

Authors:  M I Holck; C H Jones; G Haeusler
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

5.  The effect of reserpine on sympathetic, purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study.

Authors:  I Muramatsu
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

6.  Comparison between sympathetic adrenergic and purinergic transmission in the dog mesenteric artery.

Authors:  I Muramatsu; T Ohmura; M Oshita
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Two distinct alpha 1-adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta.

Authors:  I Muramatsu; S Kigoshi; M Oshita
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 9.  Evidence for more than one type of post-junctional alpha-adrenoceptor.

Authors:  J C McGrath
Journal:  Biochem Pharmacol       Date:  1982-02-15       Impact factor: 5.858

10.  Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle.

Authors:  I Muramatsu; T Ohmura; S Kigoshi; S Hashimoto; M Oshita
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

  10 in total
  5 in total

1.  Existence of different alpha(1)-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries.

Authors:  X P Yang; S Chiba
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Chloroethylclonidine: an irreversible agonist at prejunctional alpha 2-adrenoceptors in rat vas deferens.

Authors:  R Bültmann; K Starke
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

3.  Pharmacological profiles of a novel alpha 1-adrenoceptor agonist, PNO-49B, at alpha 1-adrenoceptor subtypes.

Authors:  I Muramatsu; T Ohmura; S Kigoshi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

4.  Heterogeneity of neurogenic responses in intra- and extrameningeal arteries of dogs.

Authors:  Y Kohno; T Saito; H Saito; H Aoyama; Y Nojyo; S Kigoshi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Heterogeneity of alpha 1-adrenoceptor subtypes involved in adrenergic contractions of dog blood vessels.

Authors:  Y Kohno; H Saito; M Takita; S Kigoshi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.